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a  b  s  t  r  a  c  t
Background: Visceral leishmaniasis (VL) or Kala-Azar (KA) is one of the most deadly forms
of  disease among all neglected tropical diseases. There are no satisfactory drugs or vac-
cine  candidates available for this dreaded disease. Our previous studies showed promising
therapeutic  and prophylactic efﬁcacy of the live, radio-attenuated parasites through intra-
muscular  (I.M.) and intraperitoneal (I.P.) route in BALB/c mice model.
Methods:  The T-cell proliferation level, the mRNA expression level of inducible nitric oxide
synthase  (iNOS) and tumor growth factor-beta (TGF-) genes and ﬁnally the phosphorylation
levels  of phosphoinositide dependent kinase 1 (PDK1), phosphoinositide 3 kinase (PI3K) and
p38 mitogen activated protein kinase (p38MAPK) molecules were checked in BALB/c mice
model  immunized with radio-attenuated Leishmania donovani parasites through I.M. route.
Results: Higher T-cell proliferation, increased iNOS level, and suppressed TGF- level were
found  in treated infected animal groups (100 and 150 Gy) in relation to untreated infected
animals.  Likewise, phosphorylation levels of PDK1, PI3K and p38MAPK of these two groups
were increased when compared to untreated infected controls.
Conclusion:  The clearance of the parasites from treated infected groups of animals may
be  mediated by the restoration of T-cell due to therapy with radio-attenuated L. donovani
parasites.  The killing of parasites was  mediated by increase in nitric oxide release through
PDK1,  PI3K and p38MAPK signaling pathways. A lower TGF- expression has augmentedthe  restored Th1 ambience in the 100 and 150 Gy treated animal groups proving further the
efﬁcacy  of the candidate v
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fb r a z j i n f e c t d i
ntroduction
isceral leishmaniasis (VL) or Kala-Azar (KA) has been ranked
econd  to malaria in terms of mortality and fourth for
orbidity.1 Global estimate is 50,000 new cases of VL each
ear  and 90% of VL exist in Bangladesh, Brazil, India, Nepal
nd  Sudan.2,3 The inability of KA patients to mount an anti-
eishmanial cell-mediated immune response is the hallmark
f  the disease.4 The target pathogens are rapidly developing
esistance against the available drugs including pentavalent
ntimonials.5 Absence of any licensed vaccine for combating
he  disease is another serious problem in the control man-
gement  program for VL worldwide. On the other hand, the
bservations  that people cured from VL develop protection
ediated by T helper 1 (Th1) type cellular responses against
ew  infections6 give impetus for the search of effective vac-
ine  candidates. Invading Leishmania parasites are eliminated
pon  activation of macrophages by interferon-gamma (IFN-)
ecreted by Th1 cells and natural killer (NK) cells that empower
hem  to destroy the intracellular Leishmania amastigotes by
eactive  nitric oxide (NO) mediated pathway.7 Inhibition of
itric  oxide production from inducible nitric oxide synthase
iNOS)  by the parasites makes macrophages inactive to ﬁght
gainst  the infection.8 Any vaccine for leishmaniasis should
rigger  the Th1 pathway and suppress the T helper 2 (Th2)
ytokines that exacerbate the disease. So far, many  research
roups  have undertaken serious attempts in developing a
uccessful  vaccine against the disease which include use of
ive  parasites,9 killed parasites,10 attenuated organisms,11–13
ecombinant protein vaccine,14 DNA vaccines,15,16 etc. Use
f  live non-attenuated parasites as vaccine candidate has
ot  been recommended by WHO  for a matter of safety as
eversion  of virulent forms would result in adverse side
ffects  including immunosuppression.17 Leishmania parasites
ithout  virulence factor, yet maintaining the immunogenic
ttributes, is of great interest as attenuated parasites closely
imic  the natural infection that may  lead to similar immune
esponses without the fear of infection with live virulent
arasites.18 Ionizing radiation has long been used to atten-
ate  parasites for the purpose of vaccine development.19–24
rradiation often causes loss or reduction of virulence and
eproductive ability of the pathogens but retains their
etabolic activities, morphology and antigenic proﬁle. Thus,
adio-attenuated parasites are able to trigger speciﬁc immune
esponses  without posing risk of progressive infection.25 More
nterestingly, in some cases, the radio-attenuated pathogens
re  more  immunogenic than the normal counterparts.26
se of radio-attenuated Leishmania parasites is in practice
or  quite a long time now.22,27,28 Previously our group had
hecked the prophylactic and therapeutic efﬁcacy of the irra-
iated  Leishmania donovani parasites in experimental murine
odel  and got encouraging results.29–31 The present study
s  an extension of earlier works to see whether there is any
estoration  from T cell anergy, induction of inducible iNOS
nd  suppression of Th 2 arm of immune response by studying
 cell proliferation, iNOS gene, and TGF- gene expression,
espectively. It is also an initial attempt to understand the
nderlying  mechanism of parasite clearance by macrophages
ollowing the expressions of some signaling molecules like 1 5;1  9(1):36–42  37
phosphoinositide 3 kinase (PI3K), phosphoinositide-
dependent kinase 1 (PDK1) and p38 mitogen-activated
protein kinase (p38MAPK), respectively, in the groups of ani-
mals  receiving therapy with attenuated homologous vaccine
through  I.M. route.
Materials  and  methods
Reagents
HEPES, penicillin, streptomycin, sodium bicarbonate, 2-
mercaptoethanol (2-ME), bovine serum albumin (BSA),
histopaque, fetal calf serum (FCS), RPMI 1640 medium, M
199  medium were purchased from Sigma–Aldrich. Anti-PI3K
and  anti-phospho-PI3K (p85) were  obtained from Santa Cruz
Biotech,  Inc. All other antibodies [anti-phosphoinositide-
dependent kinase 1 (PDK1) and anti-phospho-PDK1,
anti-p38 mitogen-activated protein kinase (p38MAPK) and
anti-phospho-P38MAPK] and LumiGlo reagents for chemi-
luminescence were obtained from Cell Signaling (Beverly,
MA).  Tritiated thymidine [3H]-thymidine (6.7 Ci/mmol) was
obtained  from PerkinElmer®, deoxynucleoside triphos-
phates obtained from Promega, Taq polymerase and Moloney
leukemia  virus reverse transcriptase were purchased from
Invitrogen  and RNeasy minikit was  purchased from Qiagen.
Animals,  parasites  and  infection
BALB/c mice 4–6 weeks old with almost equal weight and same
sex,  reared in Institute facilities, were used for experimental
purposes with prior approval of the Animal Ethics Commit-
tee  of the Indian Institute of Chemical Biology, Kolkata and
all  animal experimentations were performed at Indian Insti-
tute  of Chemical Biology, Kolkata, India following the National
Regulatory  Guidelines issued by Committee for the Purpose of
Control  and Supervision of Experiments on Animals (CPCSEA),
Ministry  of Environment and Forest, Govt. of India. L. dono-
vani  isolate, AG83 (MHOM/IN/1983/AG83), originally obtained
from  conﬁrmed an Indian Kala-Azar patient was  used for the
preparation  of the live-attenuated vaccine candidate. This iso-
late is maintained in Golden hamsters and the promastigotes
obtained after transforming the amastigotes from infected
animal  spleen were  cultured in medium M 199 supplemented
with 10% FCS along with 100 U/ml penicillin and 100 g/ml
streptomycin, maintained at 22 ◦C.32
Therapy  with  attenuated  parasites
L. donovani isolate, AG83, was attenuated by gamma  irradi-
ation  from a 60Co gamma  chamber with a rate of radiation
of  10 Gy/60 s at Indian Institute of Chemical Biology, Kolkata,
India.  AG83 parasites (5 × 106/BALB/c mice) were  irradiated
and washed three times in sterile phosphate buffer saline
(PBS)  and irradiated in the gamma  chamber at three differ-
ent  doses: 50, 100, and 150 Gy respectively. The description
of  the animal groups for the study was as follows: Group 1,
normal  control animals without any infection and therapeu-
tic  immunization; Group 2, infected control animals without
any  immunization, while Group 3, Group 4 and Group 5 were
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animals that had been infected and received therapeutic
immunizations with L. donovani isolate, AG83 (5 × 106 para-
sites/animal) attenuated at 50, 100 and 150 Gy doses of gamma
radiation,  respectively, at 75 days post-infection. The treat-
ment  was  repeated for three immunized groups at 15-day
interval.  The mice were  sacriﬁced 15 days after the last treat-
ment,  for experimental purposes.
T-cell  proliferation  assay
T-cell proliferation assay was  performed as described
previously.33 Brieﬂy, single cell suspensions of splenocytes
from different experimental groups of BALB/c mice were  pre-
pared  after Ficoll density gradient centrifugation and then
suspended  in complete RPMI 1640. Cells were  plated in trip-
licate  at 105 cell/well concentrations in 96-well plates and
allowed  to proliferate for 72 h at 37 ◦C in 5% CO2 incuba-
tor in the presence of SLA concentration (5 g/ml). Eighteen
hours  before they were  harvested in GFC membrane, cells
were  pulsed with 1 Ci [3H]-thymidine/well. [3H]-Thymidine
incorporation was  measured by liquid scintillation counter
(Tri-Carb  2100TR; Packard Instrument).
RNA  isolation  and  semi-quantitative  RT-PCR  analyses  of
TGF-ˇ and  iNOS  genes
RNA isolation from the splenocytes was  performed using the
RNeasy  minikit procedure (Qiagen).15 Forward and reverse
primers were  used to amplify the transcripts. Samples (1 g)
of  RNA from different experimental groups of mice were ﬁrst
utilized  for cDNA synthesis with reverse primers (IDT; Sigma)
using  Mouse Moloney Leukemia Virus reverse transcriptase
(Invitrogen) at 37 ◦C for 90 min. A common master mixture
containing deoxynucleoside triphosphates (Promega) and Taq
polymerase  (Invitrogen), as well as gene speciﬁc primers and
0.25  volume of cDNA, was  used for ampliﬁcation with an
Applied  Biosystems thermocycler. The cycling conditions for
genes of interest were  5 min  at 95 ◦C, followed by 40 cycles of
denaturation at 95 ◦C for 30 s, annealing at 56 ◦C for 40 s, and
extension at 72 ◦C for 40 s. The identities of the PCR ampliﬁed
gene  products were  veriﬁed by agarose gel electrophoresis.
Identical aliquots were  processed in parallel without reverse
transcriptase to rule out the presence of residual genomic DNA
contamination  in PCR ampliﬁcation preparations. Densito-
metric  analyses were  done using the Quantity One software
(Bio-Rad), ethidium bromide staining, and visualization under
a  UV transilluminator. For densitometric calculations, the
same  band area was  used to determine band intensity and
normalized  for HGPRT.
Western  blot  analysis
Splenocytes from different groups of animals were har-
vested,  resuspended in chilled lysis buffer (containing 20 mM
Tris–HCl  (pH 7.5), 0.5 mM EGTA, 1 mM EDTA, 0.1% (vol/vol)
2-mercaptoethanol)34 and rapidly freeze-thawed thrice and
passed  through a 26-gauge needle (10 times) for lysis. The
lysates  were  centrifuged (800 × g for 10 min  at 4 ◦C), the
supernatants were  collected, and the proteins were esti-
mated  using Bradford reagent. The supernatants were  mixed 0 1 5;1  9(1):36–42
with  Laemmli buffer, heated in a boiling water bath for
ﬁve  min  and cooled to room temperature. About 20 g
of  protein was  loaded in lanes of Sodium Dodecyl Sul-
fate  Poly Acrylamide Gels (SDS-PAGE) for electrophoresis.
After the run, the gel was  transferred to polyvinylidene
diﬂuoride membrane. Immunoblotting was performed with
appropriately diluted speciﬁc primary antibodies for PI3K
(anti-phosphoinositide 3 kinase Mab)  and phospho PDK1 (anti-
phosphoinositide-dependent Kinase 1 Mab)  and p38MAPK
(anti-p38 mitogen-activated protein kinase Mab)  respectively.
Finally,  chemiluminescence was  performed with LumiGlo
reagent as described by the manufacturer.35 Densitometry
analyses were done using Quantity1 (Bio-Rad) software.15
Statistical  analysis
Each experiment was  performed three times and results are
expressed  as means ± SD. Student’s t-test was  performed for
signiﬁcance  and a p-value of <0.05 was  considered signiﬁcant.
Western blots and RT-PCR show representative data from three
independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.
Results
Reversal  of  T  cell  responsiveness  after  therapy  with  radio
attenuated  parasites
Cell mediated immunity is impaired in Leishmania infection
characterized by marked T cell anergy to speciﬁc Leishmania
antigens.15 After observing the potential therapeutic effects of
100  and 150 Gy attenuated parasites in terms of reduction in
organ  parasite burden,31 we became interested to see whether
the  T cell anergy observed during progressive infection could
be  reversed by the treatment. Splenocytes of infected animals
(Group  2) failed to mount anti-leishmanial T cell proliferation
to  leishmanial antigens suggesting global immune unrespon-
siveness  at the active stage of the disease. Though Group 3
animals  were treated with 50 Gy radio-attenuated parasites,
they  also failed to do so. On the other hand, the splenocytes
from treated groups (Group 4 and Group 5) stimulated with
SLA  showed a signiﬁcantly (p < 0.001) higher level (3.5–4 folds)
of  T cell proliferation (Fig. 1).
Expressions  of  iNOS  and  TGF-ˇ  genes
The mRNA  expression levels of iNOS and TGF- genes (Fig. 2)
were  checked in different animal groups by RT-PCR method.
A  signiﬁcantly higher level of expression (six-fold, p < 0.001) of
iNOS  mRNA  was  seen in animals of groups 4 and 5, whereas
expression of TGF- mRNA  has been lowered by two-fold
(p  < 0.001) in the same groups of animals compared to that of
infected  group of animals (Group 2). Treated animals of Group
3  did not show such increment or decrement.
Western  blot  analyses  for  PI3K,  PDK1  and  p38MAPKIn order to score the changes, if any, in the signaling mecha-
nisms  of splenocytes of the immunized animals, immunoblot
studies were  carried out with PI3K, PDK1, and P38MAPK
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N, Normal; I, Infected; Gy, Gray; CPM, Count per minute; *, P<.05, **,  P<.01,
***, P<.001.
Fig. 1 – T cell proliferation assay in BALB/c mice groups.
Number of proliferated T cells is expressed as CPM (count
per  minute). Proliferations of T cells were  checked and
compared  between infected control group and treated
animal  groups (50, 100 and 150 Gy groups), respectively.
Higher  T-cell proliferations compared to infected animals
were  found in the treated animal groups, 100 and 150 Gy,
respectively. Left to right, bars represent N, healthy control;
I,  Infected: mice received infection only; 50, 100, 150 Gy
represent three groups of mice treated with attenuated
Leishmania donovani parasites, doses of attenuation being
50,  100 and 150 Gy absorbed doses of -radiation,
respectively. Infected (5 × 106 parasites/animal) and treated
(twice @ 5 × 106 parasites per animal in 15-day interval)
mice  were  sacriﬁced at 120 dpi. Splenocytes were  isolated
and cultured in medium RPMI-1640 in 24-well plates @
2  × 106 splenocytes/well. After 72 h the splenocytes were
pulsed with H3 thymidine and after 18 h of pulsing the
count was  taken in liquid scintillation counter. Data
represent mean ± SD of six animals per group and are
representative of three independent experiments; paired




















in  the generation of NO42 while activation of P38 MAPK isolecules (Fig. 3). These are some of the most important
olecules in triggering the production of free radicals like NO
nd ROS. In our previous intramuscular therapeutic studies,
e  identiﬁed a signiﬁcant increase of nitric oxide (NO) and
eactive  oxygen species (ROS) levels in animals of different
mmunized/treated groups.30,31 We  measured the phosphor-
lation level of these three molecules in splenocytes of the
nimals  and observed from 3.5- to 4-fold increase in phos-
horylation in 100 and 150 Gy animal groups compared to
he  infected groups (Fig. 3). This indicates the participation
f  these molecules in activating the effector molecules so that
rotection  could be achieved. Animals of Group 3 that received
mmunization with parasites attenuated with 50 Gy dose of
adiation  did not show any higher expression in terms of phos-
horylation  of any of the three signaling proteins studied here.
his  corroborates our previous observations where we noticed
hat  this group of animals had no protection and succumbed
o  the disease.30,31 1 5;1  9(1):36–42  39
Discussion
We  saw that attenuated parasites activated the microbicidal
mechanisms of macrophages in the model host body and
then  the activated macrophages efﬁciently cleared intracellu-
lar  parasites from spleen and liver cells of the protected animal
groups.  In our therapeutic study,31 the increased release of
IFN-  (three-fold higher than the infected group of animals)
from  the infected and then treated groups (100 and 150 Gy)
supported  our hypothesis that the Th2 ambience already cre-
ated  in infected conditions has been overrode by the Th1
atmosphere generated by therapeutic use of radio-attenuated
L.  donovani. While in case of our prophylactic study,30 the
radio-attenuated L. donovani parasites generated an active Th1
ambience  inside the immunized host body before the host was
exposed  to virulent L. donovani parasites which did not allow
the  disease progress. The primed and then challenged groups
of  mice showed IFN- release 15-fold higher than Interleukin 4
(IL-4) and about ﬁve-fold higher than IL-10.30 Mechanistically
thus both approaches are dependent either on the presence or
on the establishment of Th1 milieu. Attainment of the right
doses  of attenuation is still a difﬁcult task as it is directly
related to the efﬁcacy of the vaccine in one hand and to safety
issues  in another. If the dose of attenuation by gamma radia-
tion  is too low, there is a chance of reversion to virulent form of
the  pathogens causing disease progression undermining the
purpose.  If the dose of attenuation by gamma  radiation is too
high,  it will immediately kill the parasites; thus, host immune
response  will not be evoked as live promastigotes have the
potential  to induce various cells to produce IFN-, a property
which  dead promastigotes lacked.36 Manna et al.37 reported
that  the limiting dose of attenuation by gamma  radiation for
L.  donovani parasites is 20 Krad (200 Gy) up to which cells can
employ  homeoviscous adaptation to survive and compensate
the  altered conditions. In our own experiences from prophy-
lactic  and therapeutic studies, we  have seen that 100 and
150  Gy were the right doses of attenuation to evoke immune
response in experimental hosts while 50 Gy may  cause rever-
sion  as evidenced from survival kinetics and parasite burden
analyses  of spleen and liver cells of 50 Gy treated animals.
Thus, extreme caution must be taken to select the right doses
of  attenuation.
Our previous studies had shown that BALB/c mice treated
with  100 and 150 Gy radio-attenuated parasites through I.M.
route  (and also through I.P. route) have much  lower parasite
burden  and less hepato and splenomegaly compared to unim-
munized  infected animals. A signiﬁcant increase in levels of
free  radicals, an increased Th1 cytokines proﬁle and decreased
Th2  levels in these animals compared with the infected ani-
mal  groups indicated the successful clearance of intracellular
parasites in these two groups, but not in 50 Gy irradiated
group.6 Both ROS and NO are known to be involved in para-
site  killing in the early stage of Leishmania infection in mice
and  NO alone is involved in the late phase of infection.38 ROS
generation is reported to involve molecules like PI3K,39 PKC,40
ERK and Ras.38,41 P38 MAPK has been reported to be involveddependent upon PI3K activation.43Among other associated
molecules, PDK1 is an intermediate molecule in the P38MAPK
40  b r a z j i n f e c t d i s . 2 0 1 5;1  9(1):36–42

























N, Normal; I, Infected; Gy, Gray;
TGF–β, Transforming growth factor –β;
iNOS, Inducible nitric oxide synthase;
HGPRT, Hypoxanthene-guanine phophoribo syl transferase;
*, P<.05, **, P<.01, *** , P<.001.
Fig. 2 – RT-PCR in BALB/c mice groups for checking the expressions of iNOS and TGF- genes. Levels of iNOS and TGF-
genes expression were  compared between infected control group and treated animal groups (50, 100 and 150 Gy groups),
respectively. Left to right, bands and bars represent 1, healthy control; 2, Infected: mice received infection only; 3, 4, 5
represent three groups of mice treated with attenuated Leishmania donovani parasites, doses of attenuation being 50, 100
and 150 Gy absorbed doses of -radiation, respectively. Infected (5 × 106 parasites/animal) and treated (twice @ 5 × 106
parasites per animal in 15 days interval) mice were sacriﬁced at 120 dpi. Splenocytes were  isolated from which RNA was
prepared. cDNA was  prepared from RNA and PCR experiments were carried out for iNOS and TGF- gene expressions taking
HGPRT gene as the housekeeping gene for internal control. Densitometry analysis was  done and the ratio of iNOS and
TGF- expressed in the bar diagram. All data were  compared to the infected control group. Data represent mean ± SD of six
animals per group and are representative of three independent experiments; paired two-tailed Student’s t-test was
 p < 0performed. p < 0.05 was  considered signiﬁcant. *, p < 0.05; **,activation pathway,44 and P38MAPK is well known to trigger
the  production of TNF- which induces iNOS expression and








N I 50Gy 100Gy 150Gy
N, Normal; I, Infected; Gy, Gray;
PI3K, Phosphoinositide 3 kinase;
PDK1, Phosphoinositide dependent kinase 1;
p38 MAPK , p38 mitogen activated protein kinase;
P, Phospho; *, P<.05, ** , P<.01, *** , P<.001.
Fig. 3 – Western blot analysis to evaluate PDK1, PI3K and p38MA
PDK1, PI3K and p38MAPK phosphorylation were  checked and co
groups (50, 100 and 150 Gy groups), respectively. Splenocytes fro
lysates  were  prepared and run in 10% polyacrylamide gels and th
(MAbs) against non-phosphorylated and phosphorylated forms w
of each of the above mentioned molecules were  expressed as the
phospho or P) versus the internal control (-actin). Left to right, b
infection only; 50, 100, 150 Gy represent three groups of mice tre
of  attenuation being 50, 100 and 150 Gy absorbed doses of -radi
treated (twice @ 5 × 106 parasites per animal in 15 days interval) 
and  cultured in medium RPMI-1640 in 24-well plates @ 2 × 106 sp
experiments are presented here. Data represent mean ± SD value
group; paired two-tailed Student’s t-test was  performed. p < 0.05 
p < 0.001..01; ***, p < 0.001.3.9-fold higher TNF- releases in 100 and 150 Gy groups.30 In
the  present study, the expression of iNOS was observed to be
six-fold  higher in the same treatment groups. TGF- causes
PK
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N I 50Gy 100Gy 150Gy
PK phosphorylation levels in BALB/C mice groups. Levels of
mpared between infected control group and treated animal
m different groups of animals were  taken and the cell
en immunoblotted with respective monoclonal antibodies
ith  actin as an internal control. Phosphorylation status
 densitometric ratio of the phosphorylated form (labeled
ars represent N, healthy control; I, infected: mice received
ated with attenuated Leishmania donovani parasites, doses
ation, respectively. Infected (5 × 106 parasites/animal) and
mice were  sacriﬁced at 75 dpi. Splenocytes were isolated
lenocytes/well. Representative data of three similar
 of three repeat experiments with six animals in each
was  considered signiﬁcant. *, p < 0.05; **, p < 0.01; ***,


















































2b r a z j i n f e c t d i
he transcription of mRNA  involved in immune suppression,
he  hall mark of full blown KA state.35 This Th2 cytokine
ene expression is signiﬁcantly reduced (two-fold, p < 0.001) in
hese two groups suggesting that restoration of Th1 ambience
as  been initiated and established after successful therapy
ith  radio-attenuated parasites. The 100 and 150 Gy treated
nimals  also showed a signiﬁcant increase in PI3K phosphor-
lation,  which in turn activates PDK1 phosphorylation. These
re  in congruence with observations by other workers.46 After
ctivation,  PDK1 could activate different PKC isotypes, which
re  responsible for the phosphorylation of ERK molecules that
ltimately  trigger ROS generation. Activated PI3K also acti-
ates  P38 MAPK phosphorylation through Akt activation43
eading to NO production. In this preliminary study, we  have
lso  noticed higher level of p38 MAPK phosphorylation, which
ould  increase TNF- production45 and in turn induces NOS2
xpression and subsequent NO generation.45
The results of the present study showed that radio-
ttenuated live vaccine may  help the animals to recover from T
ell anergy, induce NOS2 and suppress TGF- gene expression.
he  NO and ROS induced parasite killing by macrophages, in
roups of animals treated with radio-attenuated homologous
accine, may  follow PI3K–p38MAPK mediated NO generation
n  one hand and the PI3K–PDK1 mediated ROS generation on
he  other. Further studies are in progress.
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